top of page
CVCT London.png

22nd Global CVCT Forum

Partners : FDA,

I25049_JACC (4).png
logo v3.png
CVCT 2023 multistakeholders

CROs-AROs

Academics

Principal Investigators

Patients-

Advocacy

Regulatory

(FDA, EMA)

Industry R&D

Clinicians

Lawyers

Major journal editors

Statisticians-Methodologists

Payers-HTAs

MedTech-BioTech

Investors

CVCT Chairpersons

courbes_edited_edited_edited.jpg
20250422_110127.jpeg

Faiez Zannad

Founder & chairman

UNIVERSITE DE LORRAINE, NANCY, FRA

  • Twitter
  • LinkedIn

Bertram Pitt

Co-chairman

UNIVERSITY OF MICHIGAN, ANN ARBOR, USA

  • LinkedIn
courbes_edited_edited_edited.jpg
Bertram Pitt, CVCT
courbes_edited_edited_edited.jpg
Butler_photo.jpg

Javed Butler

University of Mississippi Med Center

Jackson, Mississppi, United States

  • Twitter
  • LinkedIn

Co-chairman

&

I25049_JACC (4).png

partnership

The CVCT Forum is proud to partner with the JACC to advance our shared mission of promoting rigorous evidence generation and accelerating the global impact of cardiovascular clinical trials. Through this collaboration, CVCT and JACC are working together on session development, simultaneous and downstream publications, joint events, and strategic communication initiatives.

This partnership underscores our mutual commitment to supporting the global cardiovascular research community and ensuring that high-quality evidence drives innovation and improves health outcomes worldwide.

ANNOUNCEMENT:
LATE-BREAKING CLINICAL TRIAL SUBMISSIONS TO CVCT 2025

With potential for simultaneous submission for publication in JACC

A New Opportunity to Present Groundbreaking Research!

The CVCT Meeting is excited to announce a new feature this year: an invitation for Late-Breaking Clinical Trial Submissions! This is your chance to present impactful, cutting-edge clinical trial results at our prestigious meeting.

​

DISCOVER HERE

growth.png

Controlled growth

THE GLOBAL CVCT FORUM HAS GROWN STEADILY AND SLOWLY, WITH CONTROLLED GROWTH AS TO STAND TO ITS REPUTATION OF A “BOUTIQUE MEETING”.

CLINICAL TRIAL SCIENCE
AT ITS BEST

NO promotion,

NO exhibition,

NO marketing,

NO lecturing !

EXPAND OVER
INCLUDING
INVOLVING

03

45+

450+

DAYS
SESSIONS
SPEAKERS
bottom of page